BiotechTube
Home/Anbogen Therapeutics/Joe Hsueh, MBA
JH

Joe Hsueh, MBA

President / COO

Anbogen Therapeutics

Therapeutic Areas

Oncology

Anbogen Therapeutics Pipeline

DrugIndicationPhase
ABT-301Advanced colorectal cancerPhase 1/2

Leadership Team at Anbogen Therapeutics

TH
Tsu-an Hsu, PhD
CEO / Co‑founder
MH
Mark Horng, MD
Chief Medical Officer
View full Anbogen Therapeutics profile